# Dogecoin Cash, Inc.: financial statements, quarterly

DOGP · OTC · CIK 1360442 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dogp.md) · [Financials](/companies/dogp/financials.md) · [Filings](/companies/dogp/filings.md) · [Insiders](/companies/dogp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dogp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [271](/filings/0001096906-25-000004.md) | [234 d](/filings/0001096906-25-000535.md) | [225](/filings/0001096906-25-000877.md) | [234](/filings/0001096906-25-001380.md) | [189](/filings/0001096906-25-001794.md) | [154 d](/filings/0001096906-26-000391.md) | [184](/filings/0001096906-26-000798.md) | [192](/filings/0001096906-26-001256.md) | [191](/filings/0001096906-25-001794.md) | [171 d](/filings/0001096906-26-000391.md) | [193](/filings/0001096906-26-000798.md) | [167](/filings/0001096906-26-001256.md) |
| Cost of revenue | $k | [102](/filings/0001096906-25-000004.md) | [72.3 d](/filings/0001096906-25-000535.md) | [99.0](/filings/0001096906-25-000877.md) | [84.1](/filings/0001096906-25-001380.md) | [70.2](/filings/0001096906-25-001794.md) | [57.3 d](/filings/0001096906-26-000391.md) | [67.5](/filings/0001096906-26-000798.md) | [71.0](/filings/0001096906-26-001256.md) | [68.6](/filings/0001096906-25-001794.md) | [58.6 d](/filings/0001096906-26-000391.md) | [66.7](/filings/0001096906-26-000798.md) | [62.0](/filings/0001096906-26-001256.md) |
| Gross profit | $k | [169](/filings/0001096906-25-000004.md) | [162 d](/filings/0001096906-25-000535.md) | [126](/filings/0001096906-25-000877.md) | [150](/filings/0001096906-25-001380.md) | [119](/filings/0001096906-25-001794.md) | [96.8 d](/filings/0001096906-26-000391.md) | [117](/filings/0001096906-26-000798.md) | [121](/filings/0001096906-26-001256.md) | [122](/filings/0001096906-25-001794.md) | [113 d](/filings/0001096906-26-000391.md) | [126](/filings/0001096906-26-000798.md) | [105](/filings/0001096906-26-001256.md) |
| Operating income | $k | [(222)](/filings/0001096906-25-000004.md) | [(217) d](/filings/0001096906-25-000535.md) | [(175)](/filings/0001096906-25-000877.md) | [(198)](/filings/0001096906-25-001380.md) | [(182)](/filings/0001096906-25-001794.md) | [(139) d](/filings/0001096906-26-000391.md) | [(102)](/filings/0001096906-26-000798.md) | [(183)](/filings/0001096906-26-001256.md) | [(147)](/filings/0001096906-25-001794.md) | [(115) d](/filings/0001096906-26-000391.md) | [(157)](/filings/0001096906-26-000798.md) | [(113)](/filings/0001096906-26-001256.md) |
| Interest expense | $k | [37.3](/filings/0001096906-25-000004.md) | [(0.0) d](/filings/0001096906-25-000535.md) | [8.3](/filings/0001096906-25-000877.md) | [184](/filings/0001096906-25-001380.md) | [7.4](/filings/0001096906-25-001794.md) | [18.3 d](/filings/0001096906-26-000391.md) | [9.7](/filings/0001096906-26-000798.md) | [11.9](/filings/0001096906-26-001256.md) | [57.9](/filings/0001096906-25-001794.md) | [13.5 d](/filings/0001096906-26-000391.md) | [13.6](/filings/0001096906-26-000798.md) | [14.0](/filings/0001096906-26-001256.md) |
| Income tax | $k | [0.0](/filings/0001096906-25-000004.md) | [0.0 d](/filings/0001096906-25-000535.md) | [0.0](/filings/0001096906-25-000877.md) | [0.0](/filings/0001096906-25-001380.md) | [0.0](/filings/0001096906-25-001794.md) | [0.0 d](/filings/0001096906-26-000391.md) | [0.0](/filings/0001096906-26-000798.md) | [0.0](/filings/0001096906-26-001256.md) | [0.0](/filings/0001096906-25-001794.md) | [0.0 d](/filings/0001096906-26-000391.md) | [0.0](/filings/0001096906-26-000798.md) | [0.0](/filings/0001096906-26-001256.md) |
| Net income | $k | [(179)](/filings/0001096906-25-000004.md) | [(328) d](/filings/0001096906-25-000535.md) | [(223)](/filings/0001096906-26-000391.md) | [(391)](/filings/0001096906-26-000391.md) | [(241)](/filings/0001096906-26-000391.md) | [(926)](/filings/0001096906-26-000391.md) | [(107)](/filings/0001096906-26-001256.md) | [(7,295)](/filings/0001096906-26-001256.md) | [(178)](/filings/0001096906-26-000391.md) | [(2,463)](/filings/0001096906-26-000391.md) | [(200)](/filings/0001096906-26-001256.md) | [(138)](/filings/0001096906-26-001256.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | not reported | [83.8](/filings/0001096906-25-000004.md) | [59.0](/filings/0001096906-24-001421.md) | [61.2](/filings/0001096906-24-001698.md) | [41.4](/filings/0001096906-25-000004.md) | [34.9](/filings/0001096906-26-000391.md) | [39.5](/filings/0001096906-25-000877.md) | [50.8](/filings/0001096906-25-001380.md) | [30.0](/filings/0001096906-25-001794.md) | [29.6](/filings/0001096906-26-001256.md) | [19.5](/filings/0001096906-26-000798.md) | [11.0](/filings/0001096906-26-001256.md) |
| Current assets | $k | [163](/filings/0001096906-23-002233.md) | [160](/filings/0001096906-25-000535.md) | [79.8](/filings/0001096906-24-001421.md) | [86.7](/filings/0001096906-24-001698.md) | [59.4](/filings/0001096906-25-000004.md) | [352](/filings/0001096906-26-000391.md) | [361](/filings/0001096906-25-000877.md) | [793](/filings/0001096906-25-001380.md) | [780](/filings/0001096906-25-001794.md) | [945](/filings/0001096906-26-001256.md) | [905](/filings/0001096906-26-000798.md) | [886](/filings/0001096906-26-001256.md) |
| Total assets | $k | [2,123](/filings/0001096906-23-002233.md) | [2,021](/filings/0001096906-25-000535.md) | [1,938](/filings/0001096906-24-001421.md) | [1,945](/filings/0001096906-24-001698.md) | [1,918](/filings/0001096906-25-000004.md) | [1,711](/filings/0001096906-26-000391.md) | [1,719](/filings/0001096906-25-000877.md) | [2,076](/filings/0001096906-25-001380.md) | [2,063](/filings/0001096906-25-001794.md) | [2,227](/filings/0001096906-26-001256.md) | [2,188](/filings/0001096906-26-000798.md) | [2,168](/filings/0001096906-26-001256.md) |
| Current liabilities | $k | [431](/filings/0001096906-23-002233.md) | [485](/filings/0001096906-25-000535.md) | [608](/filings/0001096906-24-001421.md) | [765](/filings/0001096906-24-001698.md) | [750](/filings/0001096906-25-000004.md) | [716](/filings/0001096906-26-000391.md) | [747](/filings/0001096906-25-000877.md) | [782](/filings/0001096906-25-001380.md) | [797](/filings/0001096906-25-001794.md) | [840](/filings/0001096906-26-001256.md) | [870](/filings/0001096906-26-000798.md) | [904](/filings/0001096906-26-001256.md) |
| Total liabilities | $k | [1,097](/filings/0001096906-23-002233.md) | [1,263](/filings/0001096906-25-000535.md) | [1,403](/filings/0001096906-24-001421.md) | [1,648](/filings/0001096906-24-001698.md) | [1,793](/filings/0001096906-25-000004.md) | [1,839](/filings/0001096906-26-000391.md) | [1,955](/filings/0001096906-25-000877.md) | [2,071](/filings/0001096906-25-001380.md) | [2,129](/filings/0001096906-25-001794.md) | [2,256](/filings/0001096906-26-001256.md) | [2,371](/filings/0001096906-26-000798.md) | [2,489](/filings/0001096906-26-001256.md) |
| Shareholders' equity | $k | [(353)](/filings/0001096906-23-002233.md) | [(602)](/filings/0001096906-25-000535.md) | [(803)](/filings/0001096906-24-001421.md) | [(1,026)](/filings/0001096906-24-001698.md) | [(1,192)](/filings/0001096906-25-000004.md) | [(1,439)](/filings/0001096906-26-000391.md) | [(1,543)](/filings/0001096906-25-000877.md) | [(1,719)](/filings/0001096906-25-001380.md) | [(1,784)](/filings/0001096906-25-001794.md) | [(1,869)](/filings/0001096906-26-001256.md) | [(2,020)](/filings/0001096906-26-000798.md) | [(2,147)](/filings/0001096906-26-001256.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [19.9 d](/filings/0001096906-25-000004.md) | [(31.2) d](/filings/0001096906-25-000535.md) | [(24.7)](/filings/0001096906-25-000877.md) | [(100) d](/filings/0001096906-25-001380.md) | [46.8 d](/filings/0001096906-25-001794.md) | [(29.3) d](/filings/0001096906-26-000391.md) | [4.1](/filings/0001096906-26-000798.md) | [1.1 d](/filings/0001096906-26-001256.md) | [(41.9) d](/filings/0001096906-25-001794.md) | [(2.9) d](/filings/0001096906-26-000391.md) | [(13.4)](/filings/0001096906-26-000798.md) | [(8.7) d](/filings/0001096906-26-001256.md) |
| Capital expenditure | $k | not reported | [0.0 d](/filings/0001096906-25-000090.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Shares outstanding: 162,609,031 at 2026-06-30, from the cover of the [10-Q filed 2026-08-19](/filings/0001096906-26-001256.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.